Vijaypd Ceutical Launches Rs 19.25 Crore IPO on September 29
Vijaypd Ceutical, a pharmaceutical distributor, is launching its IPO from September 29 to October 1. The company aims to raise Rs 19.25 crore by offering 55 lakh equity shares at Rs 35 each. Vijaypd Ceutical serves over 170 healthcare manufacturers and manages over 19,000 SKUs across four districts. The company's revenue doubled to Rs 107.59 crore in FY25, with profit after tax growing by 190.91% to Rs 4.80 crore. IPO proceeds will fund a new API manufacturing plant, debt repayment, and general corporate purposes. The shares will be listed on the NSE SME platform on October 7.
*this image is generated using AI for illustrative purposes only.
Vijaypd Ceutical, a prominent pharmaceutical distributor, is set to enter the public market with its Initial Public Offering (IPO) scheduled to open on September 29. The company aims to raise Rs 19.25 crore through the issuance of 55 lakh equity shares priced at Rs 35 each. The IPO will remain open until October 1, providing investors a three-day window to participate.
Company Profile
Vijaypd Ceutical has established itself as a key player in the pharmaceutical distribution sector. The company serves as a dealer and stockist for over 170 healthcare manufacturers, managing an impressive inventory of more than 19,000 Stock Keeping Units (SKUs). Its operations span across four districts, with a network of 20 locations serving over 2,100 pharmacies, clinics, and nursing homes.
Financial Performance
The company has demonstrated strong financial growth:
| Fiscal Year | Revenue (Rs Crore) | Profit After Tax (Rs Crore) | Growth (%) |
|---|---|---|---|
| FY24 | 54.34 | 1.65 | - |
| FY25 | 107.59 | 4.80 | 190.91 |
Vijaypd Ceutical's revenue nearly doubled from Rs 54.34 crore in FY24 to Rs 107.59 crore in FY25. More impressively, the company's profit after tax increased by 190.91%, reaching Rs 4.80 crore in FY25.
IPO Details
- Issue Size: 55 lakh equity shares
- Price: Rs 35 per share
- Total Fundraise: Rs 19.25 crore
- Minimum Investment: Rs 1.40 lakh for 4,000 shares
- IPO Period: September 29 to October 1
- Expected Listing Date: October 7
- Listing Venue: NSE SME platform
Utilization of Funds
The company plans to utilize the IPO proceeds for the following purposes:
- Establishment of a pharmaceutical API manufacturing plant in Ahmednagar: Rs 10.83 crore
- Debt repayment: Rs 5.10 crore
- General corporate purposes: Remaining funds
Market Sentiment
As of now, the grey market premium for Vijaypd Ceutical's IPO stands at zero, indicating neutral market sentiment towards the offering.
Investors interested in the pharmaceutical distribution sector may find Vijaypd Ceutical's IPO an opportunity to consider. However, as with all investments, it is advisable to thoroughly research and consult with financial advisors before making any investment decisions.
15
